相关实验视频
Updated: May 7, 2025

11:51
Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
11.8K
设计,合成,抗癌活性和基诺林基二原衍生物的分子对接
Jia-Xing Lu1, Hai-Rong Lan1, Dai Zeng1
1School of Pharmacy, Henan University of Chinese Medicine Zhengzhou 450046 China hn_xap@163.com 18515912322@163.com hnzz_yuan@hactcm.edu.cn.
RSC advances
|January 6, 2025
概括
新的基于素的二二衍生物显示出有希望的抗癌活性,具有低毒性. 化合物3b和3c对乳腺癌细胞特别有效,诱导细胞亡,并显示出作为新型化疗剂的潜力.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 癌症研究 癌症研究
背景情况:
- 奎诺林是一种生物活性异环基基架.
- 开发新型抗癌药物,提高安全性,是至关重要的.
研究的目的:
- 为了合成和表征基于素的新型二二衍生物.
- 评估这些衍生物的抗癌活性和毒性.
- 为了研究强效化合物的作用机制.
主要方法:
- 基于素的二二衍生物 (3a-3d) 的合成.
- 使用NMR,MS,IR,UV/Vis和光光谱学的综合性表征.
- 使用MTT试验,AO/EB染色,亡和ROS检测对各种癌细胞系 (BGC-823,BEL-7402,MCF-7,A549) 和正常细胞系 (HL-7702) 的体外抗癌活性评估.
- 系统毒理学评估和尼特罗斯胺杂质分析.
- 分子对接研究以预测结合相互作用和潜在目标 (DNA,CDK2).
主要成果:
- 成功合成和表征了四种基于素的二二衍生物 (3a-3d).
- 化合物3a-3d具有较低的全身毒性,没有可检测到的尼托胺杂质.
- 所有衍生品都对测试的癌细胞系 (IC50:7.0134.32μM) 显示出显著的抗增殖活性,对正常肝细胞没有显著的细胞毒性.
- 化合物3b和3c表现出对MCF-7细胞 (IC50 ≈ 7.0 μM) 的强大活性,表现优于5-FU,并以剂量依赖的方式诱导了亡.
- 分子对接建议通过3b和3c进行DNA结合和潜在的CDK2抑制.
结论:
- 新型基于素的二二衍生物具有显著的抗癌潜力,具有有利的安全性.
- 化合物3b和3c是作为化疗剂进一步开发的特别有前途的候选物.
- 需要进一步研究3b和3c的治疗疗效和机制.
相关概念视频
Structure-Activity Relationships and Drug Design
412
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
412
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
2.9K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K
Drug Discovery: Overview
7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K

